当前位置:首页 - 行情中心 - 博济医药(300404) - 财务分析

博济医药

(300404)

  

流通市值:20.02亿  总市值:27.77亿
流通股本:2.75亿   总股本:3.82亿

博济医药(300404)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2024年第一季度实现净利润0.17亿元,每股收益0.04元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2024年第一季度最新股东权益98393.52万元,未分配利润20303.34万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2024年第一季度最新总资产145105.03万元,负债46711.51万元。

利润表
报告期2024-03-312023-12-312023-09-302023-06-30
营业总收入167,424,382.67555,832,418.6358,782,705.15232,360,196.3
营业总成本148,329,824.43538,555,406.78346,366,338.45222,341,694.12
营业利润16,614,526.5217,639,042.6617,022,123.0615,056,421.04
利润总额16,631,692.0717,629,796.0917,126,673.0315,062,593.17
净利润17,256,705.2427,192,703.3824,847,179.3118,657,792.2
其他综合收益564,543.88667,904.661,123,469.021,641,713.38
综合收益总额17,821,249.1227,860,608.0425,970,648.3320,299,505.58
资产负债表
报告期2024-03-312023-12-312023-09-302023-06-30
流动资产合计826,383,094.63815,183,866.44750,528,164.62727,045,712.03
非流动资产合计624,667,190.16613,743,208.68613,484,473.95601,851,010.18
资产总计1,451,050,284.791,428,927,075.121,364,012,638.571,328,896,722.21
流动负债合计370,629,578.38357,510,366.21346,596,104.44320,782,297.76
非流动负债合计96,485,488.4791,309,53294,336,130.0189,189,427.77
负债合计467,115,066.85448,819,898.21440,932,234.45409,971,725.53
归属于母公司股东权益合计958,936,223.85955,852,728.28887,527,556.22884,132,046.59
股东权益合计983,935,217.94980,107,176.91923,080,404.12918,924,996.68
负债和股东权益合计1,451,050,284.791,428,927,075.121,364,012,638.571,328,896,722.21
现金流量表
报告期2024-03-312023-12-312023-09-302023-06-30
经营活动现金流入小计142,260,961.86578,751,926.63402,875,591.8244,076,047.93
经营活动现金流出小计158,025,773.22542,797,785.68405,387,800.75251,489,937.54
经营活动产生的现金流量净额-15,764,811.3635,954,140.95-2,512,208.95-7,413,889.61
投资活动现金流入小计152,916,907.74895,113,511.29638,345,576.61397,764,820.21
投资活动现金流出小计306,644,423.68928,211,644.73828,034,819.48415,068,289.71
投资活动产生的现金流量净额-153,727,515.94-33,098,133.44-189,689,242.87-17,303,469.5
筹资活动现金流入小计8,768,600.5150,968,412.3167,076,939.552,738,714.85
筹资活动现金流出小计17,292,543.864,042,40819,899,653.3612,410,565.78
筹资活动产生的现金流量净额-8,523,943.386,926,004.3147,177,286.1440,328,149.07
汇率变动对现金及现金等价物的影响56,482.37449,815.68610,883.251,154,244.03
现金及现金等价物净增加额-177,959,788.2390,231,827.5-144,413,282.4316,765,033.99
期末现金及现金等价物余额217,196,530.25395,156,311.42160,511,201.49321,689,517.91
TOP↑